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A B S T R A C T
Campomanesia velutina (Cambess) O. Berg, Myrtaceae, popularly known as “gabiroba” or 
“guavira”, is used in traditional Brazilian medicine to treat several diseases, including 
inflammation and rheumatism. Extraction and isolation from leaves of the plant afforded the 
active compound myricetin 3-O-rhamnoside, also known as myricitrin. The ethanolic extract 
of leaves of C. velutina and its ethyl acetate and methanolic fractions were evaluated in 
inflammation (carrageenan-induced paw oedema) and analgesic models (acetic acid-induced 
abdominal writhing and hot plate test). Moreover, the ethanolic extract, its fractions and the 
isolated compound were also in vitro evaluated for their ability to modulate NO, TNF-Dand 
IL-10 production from J774A.1 macrophages stimulated by LPS/IFN-J In vivo assays showed 
remarkable anti-inflammatory activity of ethanolic extract, ethyl acetate and methanolic 
fractions. The antinociceptive activity of ethanolic extract and A was demonstrated in acetic 
acid-induced abdominal writhing test. In vitro assays demonstrated that ethyl acetate and 
methanolic fractions fraction and myricitrin inhibited NO production from macrophages 
J774A.1. Also Myricitrin induced production of IL-10 anti-inflammatory cytokine. None of the 
samples was able to inhibited TNF-D production. The results demonstrated for the first time 
the anti-inflammatory and antinociceptive activity of C. velutina.
© 2013 Brazilian Society of Pharmacognosy. Published by 
Elsevier Editora Ltda. 
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Introduction
Inflammation is a natural process that protects the body against 
infection and injury and is characterized by the activation of 
immune cells numerous, including monocytes, macrophages 
and neutrophils, resulting in the synthesis and release of 
a variety of inflammatory mediators, such as nitric oxide 
(NO), prostaglandins, leukotrienes, cytokines, chemokines, 
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histamine and bradykinin (Sobolewski et al., 2010). NO 
produced by macrophages plays a crucial role in antimicrobial, 
antiviral and antitumor activities. However, overproduction 
of NO is related to septic shock, vascular collapse and death 
(Chi et al., 2003). Tumor necrosis factor-D (TNF-D) is one of the 
most important pro-inflammatory cytokines, playing a crucial 
role in inflammation, stimulating the production of other 
cytokines and pro-inflammatory mediators (Baugh and Bucala, 
2001). However, the excessive production of TNF-D is related 
to the exacerbation of the inflammatory process and the 
development of autoimmune diseases (Williams et al., 2007). 
The inflammatory process can be limited by the production of 
immunomodulatory cytokines like interleukin-10 (IL-10). This 
cytokine acts as a potent inhibitor of macrophage function 
by blocking the synthesis of pro-inflammatory cytokines like 
TNF-D, IL-6 and IL-12 and by reducing the harmful effects of 
excessive activation of this cell during inflammation (Conti 
et al., 2003).
Campomanesia, Myrtaceae, can be found from northern 
Argentina to the island of Trinidad and from the Brazilian coast 
to the Andes, Peru, Ecuador and Colombia (Landrum, 1986). 
They are popularly known as “gabiroba” or “guavira”, and have 
been widely been used to treat various diseases. The bark and 
leaves of Campomanesia species, prepared by infusion, are used 
in folk medicine as depurative, anti-diarrhea, anti-rheumatic, 
anti-inflammatory, antipyretic, antiseptic of the urinary tract, 
in the treatment of diabetes, stomach problems and reduction 
of blood cholesterol (Alice et al., 1995). 
Campomanesia velutina (Cambess) O. Berg is endemic 
in Brazil, found in the Brazilian cerrado bioma, savanna 
and Brazil´s Atlantic Forest (Landrum, 1986). Although the 
traditional use of Campomanesia velutina as anti-inflammatory 
agent, there is a lack of investigations on the pharmacological 
properties of this plant. Thus, the aim of this study is to in vivo 
evaluate the antinociceptive and anti-inflammatory activity 
of ethanolic extract from Campomanesia velutina leaves and 
its fractions. In order to establish themselves the possible 
mechanism of action, the ethanolic extract, its fractions and 
the isolated flavonoid were also tested in vitro for their ability to 
modulate the production of NO, TNF-D and IL-10 from J774A.1 
macrophages stimulated by LPS/IFN-J
Materials and methods
General experimental procedures
Melting points were recorded on Buchi M-560 melting point 
apparatus. NMR spectra were obtained on a Bruker Avance 
Drx-400 MHz spectrometer. Tetramethylsilane (TMS) was 
used as internal reference and deuterated methanol (MeOD) 
as solvent. HPLC analysis was performed on Waters Liquid 
Chromatography (model Alliance 2695), equipped with vacuum 
degasser, a quaternary pump, an auto sampler, a diode array 
detector - DAD (Waters 2996) and reversed phase C18 column 
Shimadzu ODS (250 mm × 4,6 mm, 5 μm). HPLC grade reagents 
were purchase from Tedia. Water was purified by Milli-Q 
system from Millipore. Absorbance was measured on Molecular 
Devices microplate reader. Thin layer chromatograph (TLC) was 
carried out on analytical plates coated with silica gel (Merck 
60G). Spots were visualized by spraying with anisaldehyd/
sulfuric acid or by exposition to UV light. Sephadex LH-20 was 
obtained from Sigma and Poliamida-6 from Fluka. Carrageenan 
and indomethacin were purchase from Sigma Aldrich. Acetic 
acid and morphine hydrochloride were purchased from Merck 
Inc. (Brazil). Lipopolysaccharide (LPS) was obtained from Sigma 
and interferon-J (IFN-J) from RD Systems. ELISA kits were 
purchase from PeproTech (Brazil). Analytical grade reagents 
were from Merck.
Plant material
The leaves of Campomanesia velutina (Cambess) O. Berg, 
Myrtaceae, were collected in Lagoa Santa, Minas Gerais, Brazil, 
in October 2007, with permission of Instituto Chico Mendes 
de Conservação da Biodiversidade/Sistema de Autorização e 
Informação em Biodiversidade (license no 17021-5). The plant 
botanical identification was realized by Dr. Marcos E. Guerra 
Sobral, Departamento de Ciências Naturais, Universidade 
Federal de São João Del-Rei, Minas Gerais, Brazil. A voucher 
specimen was deposited in the Herbarium of UFSJ, reference 
number HUFSJ 4637.
Preparation of plant extract and fractions
The leaves of the plant materials were air-dried, powdered to 
a fine grade (410 g) and extracted by percolation with ethanol, 
at room temperature, for 27 days. The solvent was eliminated 
by evaporation under reduced pressure, resulting in the dried 
crude ethanolic extract (101 g). Part of the ethanolic extract 
(EE, 60 g) was submitted to filtration column chromatography 
on silica gel, eluted with hexane, ethyl acetate and methanol 
to yield the hexanic (H, 0.31 g), ethyl acetate (A, 8.30 g) and 
methanolic (M, 25.55 g) fractions, respectively.
Isolation
Initially were added 22 ml of acetone part of methanolic 
fraction (15 g) to afford a soluble portion and an insoluble 
portion. To the soluble portion (1.44 g) was added distilled 
water until a precipitate was formed. This was separated by 
filtration. The filtrate obtained (0.44 g) was partitioned with a 
mixture of n-buthanol/water (1:1, v/v) to yield an n-buthanolic 
and an aqueous fraction.
The n-buthanolic (0.20 g) fraction was submitted to 
Sephadex LH-20 (97 ml) column chromatograph using 
methanol as eluting solvent. The fractions (2 ml each) 
obtained from the column were collected and combining on 
monitoring TLC. The elution afforded six new fractions (1-6). 
The fraction 4 (0.053 g) was subjected to Polyamide-6 (2.0 g) 
column chromatograph using a gradient of n-hexane, ethyl 
acetate, methanol and water. A yellow powder (24 mg); mp. 
170.3-173.1°C, came from fractions eluted with methanol/water 
1:1. It was the myricitrin identified by comparing the 1H NMR 
and 13C NMR spectral data with literature. Attributions were 
confirmed by 1H -1H COSY, 1H -13C HMQC, 1H -13C HMBC and 
DEPT spectroscopy. The purification yield was 0.016% based 
on the weight of the dried leaves.  
 Marcela C.P. Michel et al. / Rev Bras Farmacogn 23(2013): 927-936 929
Fingerprints chromatograms by HPLC
EE, A, M and myricitrin were solubilized in methanol to 
yield a concentration of 5 mg/ml (EE, A and M) and 1 mg/ml 
(myricitrin), and then filtered through a 0,45 μm Millex syringe 
filters. The volume injected was 25 μl. The elution gradient 
was performed in a system with 20% methanol and 80% water 
taking 55 min to reach 100% methanol and 5 min to return to 
the initial condition. The flow rate was kept constant at 0.8 ml/
min and the separation temperature was 25°C. The UV-DAD 
detector was set to record between 200 and 600 nm and UV 
chromatograms were recorded at 254 nm.
Animals
All experiments were performed with male Swiss albino mice 
(30 ± 5 g) supplied by Animal House of Universidade Federal 
de Ouro Preto. Animals were maintained in a temperature-
controlled room (22 ± 2°C) with 12 h light/dark cycles and 
free access to food and water. The animals were limited to a 
water-only diet 12 h prior to each experiment in order to avoid 
interference with food substance absorption. The experimental 
protocols were approved, under the number 2010/060, by UFOP 
Ethical Committee of Animal Experimentation. The protocols 
were in accordance to the Guide for the Care and Use of 
Laboratory Animals, published by the US National Institute of 
Health (NIH Publication, revised in 1985).
Preparation of test samples and drugs
Indomethacin and morphine were dissolved in distilled 
water and Tween-80 (95:5). Acetic acid and carrageenan were 
dissolved in distilled water just before use. EE, A and M were 
solubilized in Tween-80, DMSO and distilled water (1:1:8) and 
0.2 ml were administered by oral gavage at doses of 100 and 
300 mg/kg. Morphine (10 mg/kg) and indomethacin (10 mg/
kg) were administered orally by gavage also (0.2 ml) and the 
reference drugs used. To the control group was given a vehicle 
(Tween-80, DMSO and distilled water 1:1:8).
Carrageenan-induced paw edema assay
The in vivo anti-inflammatory activity was determined by the 
carrageenan-induced paw edema method in mice, according to 
previously described by Winter et al. (1962) with modifications. 
The animals were divided into eight groups and the respective 
groups were treated with vehicle, indomethacin and with both 
doses (100 and 300 mg/kg) of EE, A and M. Half an hour after 
administration of the various agents, edema was induced 
by injection of carrageenan (0.02 ml, 0.1%, w/v) into the sub-
plantar tissue of the right hind paw. Only performed needle 
introduction was into the left paw, corresponding to activity 
induced by mechanical perforation (control). To measure 
variation edema, a digital caliper rule (Starret) was used. 
The paws were measured before and 1, 2, 3, 4, 5 and 6 h after 
carrageenan administration, with or without treatments. 
The paw edema was expressed in millimeters (mm) and was 
calculated as the percentage of variation between the time zero 
and 1, 2, 3, 4, 5 and 6 h after carrageenan. 
Acetic acid-induced abdominal writhing
The test was performed as described by Koster et al. (1959). 
The animals were divided into eight groups and the respective 
groups were treated with vehicle, indomethacin and with 
both doses (100 and 300 mg/kg) of EE, A and M 30 min before 
intraperitoneal (i.p.) injection of acetic acid 0.8 % v/v, 0.1 
ml/10 g body weight. The number of abdominal writhing was 
counted cumulatively over a period of 30 min immediately 
after the acetic acid injection. The antinociceptive activity was 
expressed as percentage of inhibition of abdominal writhing 
according to the following formula:
“Inhibition (%)=” (Number of Writhes [Control] – Number of Writhes [Treatment]) × 100
(Number of Writhes [Control]) 
Hot plate test
The hot-plate test was used to measure response latencies 
according to the method described by Eddy and Leimbach 
(1953). The animals were divided into eight groups and placed 
on a metal plate heated to a temperature of 56 ± 1°C and 
the time between placement of the mice on the platform 
and shaking or licking of the hind paws or jumping was 
recorded as the hot-plate latency (seconds). A cut-off period 
of 60 s was imposed to avoid tissue damage to the paws. 
Then, animals were treated with vehicle, morphine and with 
both doses (100 and 300 mg/kg) of EE, A and M. The reaction 
time of animals was recorded again 30, 60 and 120 min after 
oral administration. The significant increase in latency time 
compared to the initial observation was considered positive 
antinociceptive response.
Cell line and culture conditions
The J774A.1 (ATCC® TIB-67™) murine macrophage cell 
line were cultured in RPMI supplemented with L-glutamine 
(2 mM), sodium pyruvate (1 mM), penicillin (100 Units/ml) and 
fetal bovine serum (10%). Cells were incubated at 37°C in a 
humidified 5% CO2 atmosphere.
Cell viability 
Cell viability was measured using the MTT assay. J774A.1 
cells (3.5 × 105 cells/well) were seeded in 96-well plates and 
incubated for 2 h at 37°C in a 95% air and 5% CO2 atmosphere 
adheres to. Thereafter, cells were treated with different 
concentrations of EE, A, M (20, 40, 80, 160, 320, 640 and 1280 
μg/ml) and myricitrin (0.625, 1.25, 2.5, 5, 10, 20, 40 e 80 μg/
ml) dissolved in DMSO (1.0%) for 24 h. After incubation 
period, culture medium was replaced with 100 μl of fresh 
medium. MTT solution (dissolved in PBS) was added (final 
concentration of 0.5 mg/ml) to each well and plates were 
incubated for 4 h. The incubation was halted by the addition 
of 100 μl of sodium dodecyl sulfate 10% in hydrochloric 
acid 10 mM into each well to solubilize the formazan. The 
absorbance at 570 nm was measured using a microplate 
reader. The viability was determined based on a comparison 
with untreated cells.
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NO assay
J774A.1 cells were seeded onto a 48-well culture plate at density 
3.5 × 105 cells per well and incubated for 2 h at 37°C in a 95% air 
and 5% CO2 atmosphere adheres to. The medium was carefully 
discarded and 200 μl of fresh medium was added. Cells were 
treated with different non-cytotoxic concentrations of EE, A, 
M and myricitrin dissolved in DMSO for 1 h before stimulation 
with LPS and IFN-J (25 ng/ml and 25 UI/ml, respectively) for 24 
h. The presence of nitrite, a table oxidized product of NO, was 
measured in cell culture medium using Griess reagent (Green 
et al., 1982). Briefly, 50 μl of supernatant was transferred to a 
96-well plate and incubated with 100 μl of Griess Reagent for 
10 min at room temperature. The absorbance was measured 
at 570 nm using a microplate reader. NO concentration was 
determined using comparison with a sodium nitrite standard 
curve. The end concentration of DMSO was adjusted to less 
than 0.3% for all treatments. Dexamethasone was used as a 
reference standard.
Measurements of TNF-D and IL-10 levels
J774A.1 cells were seeded onto a 48-well culture plate at density 
3.5 × 105 cells per well and incubated for 2 h at 37°C in a 95% air 
and 5% CO2 atmosphere adheres to. The medium was carefully 
discarded and 200 μl of fresh medium was added. Cells were 
treated with different non-cytotoxic concentrations of EE, A, M 
and myricitrin dissolved in DMSO for 1 h before stimulation 
with LPS and IFN-J (25 ng/ml and 25 UI/ml, respectively) for 
24 h. After incubation period, the supernatant was collected 
and used to estimate the levels of TNF-D and IL-10 by specific 
ELISA kits according to the manufacturer´s instruction. The end 
concentration of DMSO was adjusted to less than 0.3% for all 
treatments. Dexamethasone was used as a reference standard.
Statistical analysis
In vivo results presented were the means ± SEM from 
experiments performed with eight animals per group. In vitro 
results were obtained from three independent experiments 
in duplicate and were presented as mean ± SEM. Results were 
submitted to analysis of variance (One-way ANOVA) followed 
by Dunnett’s test for analysis of test groups compared to control 
group and the analysis of variance (One-way ANOVA) followed 
by Bonferroni’s test for analysis between groups. The differences 
were considered significant when p-values were less than 0.05 
(p < 0.05). Statistical analysis was performed using the PRISM 
software (GraphPad Software, Inc., San Diego, CA, version 5.01).
Results and discussion
Fingerprints from EE, A and M were obtained order to 
establish themselves in the chromatographic pattern and 
level of complexity of samples. The HPLC profile of EE, A and 
M at 254 nm were presented in Fig. 1. At first sight, fingerprint 
chromatogram off EE (Fig. 1A) did not reveal the complex 
metabolic profile. However, integration of the chromatogram 
showed the presence of 58 peaks with the main peaks at 
retention time until 30 min. The A fraction showed a complex 
metabolomic profile (Fig. 1B) with a concentration of peaks 
in retention time between 30 and 45 min. M fraction also 
showed the chromatographic profile not too complex and 
the integration revealed the presence of 46 peaks with the 
main peaks at retention time until 25 min (Fig. 1C). The HPLC 
profile demonstrated that from the fractionation of EE were 
obtained two fractions with different profiles metabolomics, 
which fulfilled the objective of obtaining samples of different 
composition. Myricitrin was recognized in EE chromatogram 
by comparing retention time and UV spectra with purified 
substance. The HPLC chromatogram of the purified substance 
was shown in Fig. 1D. 
The anti-inflammatory effect of the crude ethanolic extract 
of C. velutina and its fractions were evaluated in carrageenan-
induced paw edema, an animal model widely used for the 
Figure 1 - HPLC chromatograms of ethanolic extract (A), A 
fraction (B), M fraction (C) and myricitrin (D) obtained by 
HPLC-UV-DAD at 254 nm.
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screening of anti-inflammatory compounds and has been used 
to assess often the anti-oedematogenic effect of natural products, 
exhibiting a high degree of reproducibility (Morris, 2003). The 
edema produced by carrageenan injection remains located in the 
area of administration (Cicala et al., 2007) and is characterized by 
biphasic response which involves the release of several mediators, 
cell migration and plasma exudation (Loram et al., 2007).  The 
first phase (0-2.5 h) is associated with the release of serotonin and 
histamine in the first 90 min, and bradykinin in an intermediate 
stage (90-150 min) (Moncada and Higgs, 1993). On the second phase 
(3-4 h) the edema is maintained by the production of PG’s after 
the induction of COX-2 and NO release after iNOS expression in 
activated leukocytes infiltrated the edema (Salvemeni et al., 1996). 
At this time the swelling reaches its largest volume. 
The group was treated with vehicle was considered as 
maximum of inflammation and all others were treatments 
compared to this group. Those shown in Table 1, the effect 
of indomethacin began in the second hour after carrageenan 
injection and remained throughout the experiment. Oral treatment 
with EE at major dose (300 mg/kg) was effective in reducing the 
edematogenic response from first hour after carrageenan injection 
and also remained throughout the experiment. Moreover, the anti-
inflammatory activity of EE was similar to indomethacin during the 
entire experiment.  These results suggest that EE acts at different 
phases of carrageenan-induced inflammatory process, probably 
by inhibiting the release and/or actions of several inflammatory 
response mediators involved at, like vasoactive amines, kinins, PG 
and NO. Fractions A and M significantly inhibited the edema from 
third hour after carrageenan injection. Thus, the activity of these 
fractions only in the second phase of the inflammatory process is 
an indication that the mechanism of action of substances presents 
in A and M fractions are related to PG and NO.
In order to elucidate the possible mechanism of anti-
inflammatory action of EE, A and M, they were evaluated for their 
Treatment Swelling thickness (%)
(After carrageenan) 1 h 2 h 3 h 4 h 5 h 6 h
Control conditiona 1,88 ± 1,10
d 0,27 ± 3,32d 4,14 ± 2,81d 4,27 ± 3,12d 3,01 ± 1,95d 1,05 ± 1,56c
Vehicle 14,22 ± 1,84 22,00 ± 2,84 30,22 ± 3,10 25,58 ± 3,99 18,36 ± 4,19 12,32 ±  2,97
Indomethacin 6,62 ± 1,93 11,04 ± 1,93
b 15,25 ± 2,79c 10,65 ± 2,25c 5,80 ± 2,61c 0,72  ±  2,18c
EE 100 mg/kg 13,77 ± 2,89 17,97 ± 3,10 18,26 ± 3,64
b 13,24 ± 3,87b 8,10 ± 2,59b 1,51 ± 1,90c
EE 300 mg/kg 4,86 ± 2,60
b 11,47 ± 2,67b 14,40 ± 2,98c 11,20 ± 2,93c 6,92 ± 1,86b 1,53 ± 1,38c
A 100 mg/kg 12,24± 2,09 15,74 ± 2,57 10,50 ± 3,62
d 15,43± 3,69 22,09 ± 2,66 2,00 ± 2,33c
A 300 mg/kg 12,86 ± 1,64 15,01 ± 1,69 4,70 ± 2,39d 15,14 ± 1,59 18,70 ± 2,33 2,55 ± 2,49c
M 100 mg/kg 11,96 ± 2,01 13,67 ± 1,61 19,27 ± 2,26 11,67 ± 1,60b 5,85 ± 1,65b 2,36 ± 1,37c
M 300 mg/kg 11,78 ± 1,89 13,15 ± 1,30 7,99 ± 1,86d 8,20 ± 3,17# 7,41 ± 1,32b 2,54 ± 1,32c
Results represent the mean ± S.E.M. variation of the percentage  of full length between the dorsal and ventral faces of the paws before and 1, 2, 3, 
4, 5 and 6 h after carrageenan.  
aWithout carrageenan. 
bp < 0.05. 
cp < 0.01. 
dp < 0.001, when compared to the group treated with vehicle (ANOVA followed Dunnett’s test).
Table 1
Effect of oral administration of ethanolic Campomanesia velutina  extract (EE) and its ethyl acetate (A) and methanolic (M) 
fractions on carrageenan-induced paw edema.
ability to modulate NO, TNF-D and IL-10 production from J774A.1 
macrophages stimulated by LPS/IFN-J
First of all, the viability of the J774A.1 macrophages in 
the presence of different concentrations of EE, A, M and 
myricitrin were evaluated. The cytotoxicity on J774A.1 cells 
was negligible and did not show statistic difference when 
compared to the control. The exception occurred for the 
A fraction, since the concentration of 640 and 1280 μg/ml 
showed cell viability lower than 90%. Thus, EE, A and M 
fractions were assayed in vitro using concentrations lower 
than 640 μg/ml. Myricitrin was in vitro assayed using 
concentrations lower than 20 μg/ml.
Inhibition of NO production was evaluated in supernatants of 
J774A.1 cells stimulated by LPS (25 μg/ml) and IFN-J (25 UI/ml) in the 
presence or absence of the EE, A and M. The NO is produced from 
L-arginine by at least three isoforms of NOS. Inducible isoform of 
NOS (iNOS) is expressed due to the action of inflammatory stimuli 
generating large amounts of NO, toxic for bacteria and tumor cells. 
Although physiological production of NO plays an important role 
in host defense, overproduction of NO has been implicated in the 
pathogenesis of conditions such as bacterial sepsis and chronic 
inflammation. Therefore, an agent that inhibits the production 
of NO might be useful for treatment of inflammatory diseases 
(Punteree et al., 2004). In vitro results demonstrated that in the 
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absence of samples, unstimulated J774A.1 cells secreted basal 
levels of NO, while LPS/IFN-J stimulation resulted in NO production 
increase (Fig. 2). EE and M were not able to reduce NO production 
from J774A.1 macrophages (Fig. 2A and C). However, the fraction 
significantly inhibited NO release from J774A.1 macrophages in all 
concentrations evaluated (Fig. 2B),  this might be demonstrated 
that one of the possible mechanism of action of this fraction.
The production of TNF-D and other pro-inflammatory 
interleukins is a crucial part of the immune response to many 
inflammatory stimuli. The local effect of TNF-Dcan be considered 
beneficial to the host. However, overproduction leads to severe 
systemic toxicity and even death (Herath et al., 2003). J774A.1 cells 
in the absence of any stimulus secreted basal levels of TNF-D, 
while LPS/IFN-J stimulation resulted in an appreciable increase of 
TNF-D level (Fig. 3). EE was able to inhibit the TNF-D production, 
but this reduction was not significant compared to control (Fig. 3A). 
A and M did not produce significant inhibition in any evaluated 
concentration (Fig. 3B and C). The results obtained suggest that the 
mechanism of action of anti-inflammatory activity observed for C. 
velutina does not involve inhibition of this cytokine. 
Figure 2 - A, effect of the ethanolic extract (EE); B, effect 
of ethyl acetate fraction (A); C, effect of methanolic 
fraction (M) on NO production by LPS/IFN-J stimulated 
J774A.1 macrophages. The cells were treated with EE, 
A and M dissolved in DMSO at different non-cytotoxic 
concentrations for 1 h and then stimulated with LPS (25 
μg/ml) and IFN-J (25 UI/ml) for 24 h. Supernatants were 
collected and nitrite (NO) concentration was determined 
by Griess reagent. Data are represented as mean ± S.E.M. 
*p < 0.05.
**p < 0.01.
***p < 0.001 compared with LPS/IFN-J-stimulated 
macrophages alone (ANOVA followed Dunnett’s test).
Figure 3 - A, effect of the ethanolic extract (EE); B, effect of 
ethyl acetate fraction (A); C, effect of methanolic fraction 
(M) on TNF-Dproduction by LPS/IFN-J stimulated J774A.1 
macrophages. The cells were treated with EE, A and M 
dissolved in DMSO at different non-cytotoxic concentrations 
for 1 h and then stimulated with LPS (25 μg/ml) and IFN-J 
(25 UI/ml) for 24 h. Supernatants were collected and TNF-D
concentration was determined by specific ELISA kit. Data are 
represented as mean ± SEM. 
*p < 0.05.
**p < 0.01.
***p < 0.001 compared with LPS/IFN-J-stimulated 
macrophages alone (ANOVA followed Dunnett’s test).
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Treatment Number of writhes Inhibition (%)
Vehicle 58.62 ± 7.09 -
Indomethacin 18.37 ± 5.44 68.66
b
EE 100 mg/kg 34.37 ± 7.53 41.37
EE 300 mg/kg 9.37 ± 4.59 84.01
c
A 100 mg/kg 20.25 ± 7.09 65.45
a
A 300 mg/kg 16.75 ± 8.19
71.43 
M 100 mg/kg 33.00 ± 13.93 43.71
M 300 mg/kg 38.71 ± 10.08 33.96
Results represent the mean ± SEM (n = 8) of the number of abdominal 
writhing after i.p. acetic acid administration.  
ap < 0.05 
bp < 0.01. 
cp < 0.001, when compared to the group treated with vehicle (ANOVA 
followed Dunnett’s test).
Table 2
Effect of oral administration of ethanolic Campomanesia 
velutina  extract (EE) and its ethyl acetate (A) and methanolic 
(M) fractions in the acetic acid-induced abdominal writhing 
test.
It is well established that inflammatory response may be 
resolved through the clearance of the inflammatory cells or through 
the release of endogenous anti-inflammatory mediators such as 
IL-10. IL-10 is a late cytokine produced by several cell types that has 
a special physiological significance in limiting and preventing an 
excessive immune response and in limiting collateral damage (Sabat 
et al., 2010). Thus, the effect of EE, A and M in IL-10 production from 
J774A.1 macrophages stimulated by LPS/IFN-J was evaluated. 
In the absence of samples, cells secreted appreciable amounts 
of IL-10 after stimulation with LPS/IFN-J, while unstimulated 
J774A.1 cells secreted smaller significant levels of IL-10 
(Fig. 4). Unfortunately, EE, A and M induced a significant inhibition 
of IL-10 production at all concentrations tested (Fig. 4A, B and C). 
Therefore, the anti-inflammatory activity of EE, A and M are not 
related to increased production of IL-10. 
The cytokines network is very complicated and until 
now isn´t completely understood (Bony et al., 2012). 
Despite the results obtained on in vitro tests, EE, A and 
M demonstrated a strong anti-inflammatory activity, 
which suggests a general inhibitory effect on macrophage 
activation, probably acting on different targets.
The antinociceptive potential of EE and its A and M 
fractions was evaluated by both chemical and thermal 
nociception induced models. Acetic acid i.p. injection 
produced 58.62 ± 7.09 writhes in the group treated with 
vehicle (control group). Indomethacin significantly reduced 
the number of writhes with 68.66% of inhibition. EE (300 
mg/kg) and A (100 and 300 mg/kg) produced significant 
reduction in the number of abdominal writhing with 
84.01, 65.45 and 71.43% of inhibition, respectively. The 
antinociceptive activity of these groups was similar to 
indomethacin (Table 2) and there is no statistic difference 
between indomethacin and these groups. Notice that EE 
at the dose of 300 mg/kg was more active than A and M. 
These findings suggest that the highest activity of EE can be 
attributed to the synergism between the various molecules 
present in the extract. Thus, the fractionation of the crude 
extract resulted in loss of synergistic effects, leading to 
reduction of antinociceptive activity to A fraction and 
absence of antinociceptive activity to M fraction. 
The acetic acid-induced writhing abdominal visceral pain 
model is employed as a screening tool for the assessment 
of antinociceptive or anti-inflammatory activity of new 
Figure 4 - A, Effect of the ethanolic extract (EE); B, effect of 
ethyl acetate fraction (A); C, effect of methanolic fraction 
(M) on IL-10 production by LPS/IFN-J stimulated J774.A1 
macrophages. The cells were treated with EE, A and M 
dissolved in DMSO at different non-cytotoxic concentrations 
for 1 h and then stimulated with LPS (25 μg/ml) and IFN-J 
(25 UI/ml) for 24 h. Supernatants were collected and IL-10 
concentration was determined by specific ELISA kit. Data are 
represented as mean ± SEM. 
*p < 0.05.
**p < 0.01.
***p < 0.001 compared with LPS/IFN-J-stimulated 
macrophages alone (ANOVA followed Dunnett’s test).
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analgesic agents (Souza et al., 2009). However, despite 
good sensitivity of this test, it is considered nonspecific 
because the nociceptive action of acetic acid appears to 
involve different mechanisms (Le Bars et al., 2001) such as 
the release of endogenous mediators by the sympathetic 
system (Duarte et al., 1988), opioid mechanisms (Collier 
et al., 1968) and the increase in the level of COX and LOX 
products as well as the release of many inflammatory 
mediators like bradykinin, substance p and cytokines 
(TNF-D, IL-1Eand IL-8) by peritoneal macrophages and 
mast cells (Ikeda et al., 2001). Thus, in order to avoid 
misinterpretation, the hot plate test was employed. This 
model of nociception is a sensitive and specific test used 
to show the involvement of central mechanisms (Le Bars 
et al., 2001). The oral administration of EE, A and M did 
not produce a significant prolongation of latency times, 
indicating that analgesic effects does not involve central 
mechanisms of pain inhibition. Thus, the antinociceptive 
effect of EE and its A fraction is peripherally mediated and 
may be related to inhibition of the production and/or action 
of mediators involved in inflammation such as bradykinin, 
substance P, TNF-D, IL-1E, IL-8, NO, which can interfere with 
the transduction mechanism signal of primary afferent 
nociceptors (Ong et al., 2011). In vitro results showed that 
EE and A did not reduce TNF-D production on J774A.1 cells. 
However, unlike EE, the fraction was able to reduce NO 
production, indicating an involvement of NO pathway on 
antinociceptive activity of this fraction.
Myricitrin was isolated from M fraction obtained from 
C. velutina ethanolic extract and was the first flavonoid 
isolated on this specie. Previous studies demonstrated 
the anti-inflammatory and antinociceptive activity of this 
flavonol (Meotti et al., 2006) and its ability to inhibit NO 
production from RAW 264.7 macrophages stimulated by 
LPS (Chen et al., 2000) and TNF-Dproduction from RAW 
264.7 cells (Shimosaki et al., 2011). Thus, the contribution 
of myricitrin for the observed anti-inflammatory and 
analgesic activity was also evaluated on in vitro tests. In 
this study, was not capable to myricitrin inhibited TNF-D
production from J774A.1 macrophages stimulated by LPS 
and IFN-J on concentrations tested (Fig. 5B). However, 
myricitrin significantly inhibited NO production (Fig. 5A) 
and increased IL-10 secretion in macrophages stimulated 
by LPS/IFN-J (Fig. 5C). It is interesting to note the effect over 
NO and IL-10 production vanishes at higher concentrations. 
This may be attributed to post-transcriptional effects of 
this flavonoid, since it is well established that IL-10 can 
be regulated by post-transcriptional mechanisms in 
macrophages (Németh et al., 2005).  Also it is possible that 
at concentrations above 1.25 mg/ml myricitrin is acting as 
a pro-oxidative molecule (Comalada et al., 2006). These 
results indicate that myricitrin may contribute for the anti-
inflammatory and antinociceptive activity of the species.
The anti-inflammatory and antinociceptive activity of 
C. velutina observed after oral administration of EE, A and 
M suggests that active compounds are well absorbed by the 
gastrointestinal tract. Moreover, activities of C. velutina could 
be attributed to the action of different classes of substances, 
probably acting on different targets of inflammation, since 
extracts with different composition showed anti-inflammatory 
and antinoceptive activity. 
Campomanesia velutina is used in traditional Brazilian medicine 
for the treatment of painful and inflammatory conditions. The 
results of the present study demonstrate, for the first time, that 
Campomanesia velutina anti-inflammatory and antinociceptive 
activity presents. Although the complete mechanisms underlying 
these actions remain to be elucidated, the anti-inflammatory 
activity seems to involve vasoactive amines, kinins, prostaglandins, 
NO and IL-10 pathway. The antinociceptive activity is mediated by 
peripheral mechanisms. The isolated compound myricitrin seems 
to contribute to anti-inflammatory and antinociceptive activity, 
since it was able to modulate NO and IL-10 production. However, 
further studies are necessary to corroborate its use in humans. 
Figure 5 - Effect of myricitrin on NO (A), TNF-D (B) and IL-10 
(C) production by LPS/IFN-J stimulated J774.A1 macrophages. 
The cells were treated with myricitrin dissolved in DMSO 
at different non-cytotoxic concentrations for 1 h and then 
stimulated with LPS (25 μg/ml) and IFN-J (25 UI/ml) for 24 h. 
Supernatants were collected and nitrite (NO) concentration 
was determined by Griess reagent, TNF-Dand IL-10 
concentration was determined by specific ELISA kit. Data are 
represented as mean ± S.E.M. 
*p < 0.05.
**p < 0.01.
***p < 0.001 compared with LPS/IFN-J-stimulated 
macrophages alone (ANOVA followed Dunnett’s test).
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